Results 11 to 20 of about 113,275 (214)

Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin : an open-label dose escalation study [PDF]

, 2011
Introduction: As the immunosuppressive potency of 15-deoxyspergualin (DSG) has been shown in the therapy of renal transplant rejection and Wegener's granulomatosis, the intention of this study was to evaluate the safety of DSG in the therapy of lupus ...
Hauser, Ingeborg A., Tesar, Vladimir, Heinzel, Peter A., Hiepe, Falk, Peter A Heinzel, Wilhelm H Schmitt, Vladimir Tesar, Ulf Müller-Ladner, Woehling, Heike, Nemoto, Kyuichi, Heike Woehling, Hanns-Martin Lorenz, Müller-Ladner, Ulf, Kyuichi Nemoto, Falk Hiepe, Lorenz, Hanns-Martin, Tarner, Ingo, Ingo Tarner, Tobias Alexander, Schmitt, Wilhelm H., Ingeborg A Hauser, Alexander, Tobias   +21 more
core   +1 more source

Tubulointerstitial nephritis without glomerular crescent formation as an underestimated subgroup of renal involvement among microscopic polyangiitis patients: A case report

Clinical Case Reports, 2021
Although extra‐glomerular involvement of microscopic polyangiitis is not regarded as a characteristic finding of the disease, tubulointerstitial nephritis should be considered as a new subclass of renal involvement.
Se Hee Kim, Hae‐Rim Kim, Sang‐Heon Lee, Hong Ki Min   +3 more
doaj   +1 more source

Lupus Nephritis: Current Perspectives and Moving Forward [PDF]

, 2022
Julia Lichtnekert, Hans-Joachim Anders, Maciej Lech Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, München, GermanyCorrespondence: Maciej Lech, Medizinische Klinik und Poliklinik IV Klinikum
Lichtnekert J, Lech M, Anders HJ
core  

Freqüência de síndrome metabólica em pacientes com nefrite lúpica Frequency of metabolic syndrome in patients with lupus nephritis

Revista Brasileira de Reumatologia, 2008
INTRODUÇÃO: Os pacientes com lúpus eritematoso sistêmico (LES) apresentam morbimortalidade importante por doenças cardiovasculares (DCV). A síndrome metabólica (SM) é um transtorno complexo representado por um conjunto de fatores de risco para DCV ...
Bernardo Matos da Cunha, Evandro Mendes Klumb, Jaqueline Quintanilha Moura, Amanda Santos, Geraldo da Rocha Castelar Pinheiro, Elisa M. N. Albuquerque, Roger Abramino Levy   +6 more
doaj   +1 more source

SUPERPERMEABILITY IN NEPHRITIS [PDF]

Archives of Internal Medicine, 1913
In a series of studies of renal function in the various clinical types of nephritis undertaken this year, I have been impressed by a striking peculiarity in the behavior to the functional tests of four cases, 1 all of which, clinically and from the urine examination, apparently belong to one group.
openaire   +2 more sources

Autoantibodies against complement C1q in systemic lupus erythemathosus [PDF]

, 2008
Complement and C1q, the first component of the classical pathway of activation of the complement system, are considered to be involved in the pathogenesis of systemic lupus erythematosus (SLE), a systemic autoimmune disease.
Bigler, Cornelia
core   +1 more source

A Patient with Henoch-Schönlein Purpura with Intussusception and intractable Nephritis [PDF]

Childhood Kidney Diseases, 2016
Henoch-Schönlein purpura (HSP) is the most common vasculitis in children, mainly affecting the small vessels of the skin, joints, gastrointestinal tract, and kidneys.
Min Kyoung Seo, Jeong Hong, Hyun Ee Yim, Ki Soo Pai   +3 more
doaj   +1 more source

Experience of Using Activated Protein C in a Patient With Emphysematous Pyelonephritis Receiving Percutaneous Nephrostomy Drainage

International Journal of Gerontology, 2010
Drotrecogin alfa, a type of recombinant human activated protein C, has potential to reduce the mortality in severe sepsis, but may simultaneously increase the risk of serious bleeding events.
Yueh-Hung Lin, Shou-Chuan Shih, Chien-Liang Wu, Yi-Chou Chen, Yu-Wei Chen, Shih-Yi Lee   +5 more
doaj   +1 more source

Do we still need renal biopsy in lupus nephritis? [PDF]

, 2016
The natural course of systemic lupus erythematosus (SLE) is characterized by periods of disease activity and remissions. Prolonged disease activity results in cumulative organ damage.
Ewa Haładyj, Ricard Cervera
core   +1 more source

Prognostic Impact of Genetic Variants of MECP2 and TIRAP on Clinical Outcomes of Systemic Lupus Erythematosus with and without Nephritis

Biomolecules, 2021
Systemic lupus erythematosus (SLE) is a chronic autoimmune illness with a growing prevalence in many populations. Few studies have examined genetic predisposition to SLE, so we aimed to examine the clinical impact of the genetic polymorphisms MECP2 ...
Safaa I. Tayel, Nashwa M. Muharram, Dina S. Fotoh, Hany S. Elbarbary, Huda I. Abd-Elhafiz, Eman A. El-Masry, Ahmed E. Taha, Shimaa E. Soliman   +7 more
doaj   +1 more source